Mitsubishi Chemical Holdings Corporation (MCHC) was jointly established by Mitsubishi Chemical Corporation and Mitsubishi Pharma Corporation (Current Mitsubishi Tanabe Pharma Corporation) with a stock-for-stock exchange effective in October 2005. Then, Mitsubishi Tanabe Pharma Corporation, formed by the merger between Mitsubishi Pharma Corporation and Tanabe Seiyaku Co., Ltd. began operation on October 1, 2007. Subsequently, the functional products businesses of the MCHC Group were restructured and consolidated as a new company, Mitsubishi Plastics, Inc., on April 1, 2008. Then, Mitsubishi Rayon Co., Ltd. joined the MCHC Group on April 1, 2010.Further, the healthcare-related businesses of the MCHC Group were integrated into a new company, Life Science Institute, Inc. on April 1,2014.Then TAIYO NIPPON SANSO CORPORATION joined the MCHC Group on November 12,2014.
Thus the MCHC Group currently consists of six business companies: Mitsubishi Chemical Corporation, Mitsubishi Tanabe Pharma Corporation, Mitsubishi Plastics, Inc., Mitsubishi Rayon, Co., Ltd., Life Science Institute, Inc. and TAIYO NIPPON SANSO CORPORATION and their group companies. As the holding company, MCHC will further develop and enhance its Group portfolio so as to increase overall Group value.
Mitsubishi Chemical Holdings Corporation aims to achieve a truly KAITEKI* society through formulation of group-wide business strategies, resource allocation, and effective business management as the holding company of five business companies.
*KAITEKI means “comfort” in Japanese.
Mitsubishi Chemical Corporation provides a wide variety of technology, materials, and products based on chemistry and utilizing a broad spectrum of technology to support industrial progress and enhance the quality of people’s lives. In addition to providing convenience, economic value, and solutions for client business problems, Mitsubishi Chemical Corporation aims to fulfill its potential of chemistry, protecting the global environment and ensuring a sustainable society.
Our philosophy is “to contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, Mitsubishi Tanabe Pharma Corporation is implementing a wide range of business activities to realize our vision “to be a global research-driven pharmaceutical company that is trusted by communities,” through the creation and provision of superior pharmaceuticals.
As a company that provides a broad spectrum of functional products and materials over a wide variety of industries, Mitsubishi Plastics, Inc. is moving forward to become a development company taking a role as a good partner of customers. The challenges faced in achieving this goal include continuing to create products of higher value and contributing to the development of more affluent societies.
In the MMA (methyl methacrylate) business domain, Mitsubishi Rayon Co., Ltd. is the world’s reading manufacturer of monomers and polymers. Based on the deeprooted monomer and polymer expertise of our synthetic plastics and fiber businesses, we always meet new market demand as and when it arises. Our products range from advanced telecommunications and aerospace materials to healthcare and environmental technologies that support daily lifestyles and contribute to a better future for all.
We promote providing wide-ranging solutions in the fields of health,medical ICT, advanced medication and new pharmaceutical development supporting industry.
TAIYO NIPPON SANSO CORPORATION is firmly supporting the activities of companies in the wide range of industries including steel, chemicals, electronics, energy and medical by supplying oxygen, nitrogen, argon, and other industrial gases. We will continuously contribute to the industrial development across the world through the gas supply, while fully utilizing our extensive experience of more than 100 years and our unique technologies.